Some adults aged 50 and over are paying £460 ($609) for a private two-dose Shingrix course, while studies have linked shingles vaccination with a lower risk of dementia. Private providers offer the vaccine to adults who are not currently eligible through the NHS programme, while Welsh research found a 20 per cent relative reduction in new dementia diagnoses over seven years.

Boots prices the full course at £460 ($609), with the two doses given two to six months apart. Immunocompetent adults who are not yet eligible under the phased NHS programme generally have to pay privately if they want the vaccine before becoming eligible.

Studies Link Shingles Vaccine Dementia Risk to a Fifth Drop

A Stanford-led natural experiment published in Nature on 2 April 2025 used a Welsh cutoff of 2 September 1933. Among 282,541 older adults followed for seven years, the live zoster vaccine cut the chance of a new dementia diagnosis by 3.5 percentage points, a 20.0 per cent relative reduction, stronger in women.⁠ Shingles itself fell by about 37 per cent.

A 2024 Nature Medicine analysis associated Shingrix with 17 per cent more dementia diagnosis-free time than the older live vaccine, equivalent to 164 extra days among those who later developed dementia. Researchers caution that these observational findings do not prove that Shingrix prevents dementia, although the association remained after analyses designed to account for healthy-vaccinee bias.

Oxford psychiatrist Paul Harrison said a 20 per cent reduction would matter because few tools slow onset.⁠ Steve Jones wrote on X: 'Get the shingles vaccine, it has a good reputation, shingles sucks big time and a recent study found a link between folks who got this vaccine and had a much lower risk of dementia.'⁠

Read more

Private Jabs Fill the Gap in a Phased NHS Rollout

Immunocompetent adults who fall outside the current NHS eligibility cohorts must pay if they want the vaccine now. From 1 September 2023, the programme switched to two doses of Shingrix and began a phased expansion that is due eventually to make people turning 60 routinely eligible.

Shingrix was more than 90 per cent effective against shingles in trials in people aged 50 and over.⁠ Usual side effects are a sore arm, fever or aches. It cannot cause shingles. Shingrix is primarily recommended to reduce the risk of shingles and its complications, including long-lasting nerve pain. GSK recorded Shingrix sales of £3.6 billion($4.8 billion) in 2025.⁠

Signs Symptoms and Ways To Lower Dementia Risk

NHS guidance lists early signs that are not a normal part of ageing: memory loss for recent events, trouble concentrating, difficulty with familiar tasks such as handling change, struggling to find words, confusion about time or place, and mood shifts.⁠ Other types can add movement problems, hallucinations or personality change.⁠

Prevention advice remains the surest course. Eat a balanced diet, keep a healthy weight, stay physically and socially active, stop smoking, drink no more than 14 units of alcohol a week, and keep blood pressure and hearing in check.⁠ Anyone worried about memory should see a GP.⁠

People who are not yet eligible for NHS vaccination can choose to pay privately for the course. Eligible patients can wait for a free invitation. Randomised trials now underway should help establish whether the observed association is causal.

Read more